Anne Mette

May 22, 2024 | academic.oup.com | Kongens Lyngby |Biomedical Informatics |Anne Mette |Austrian Agency

The macrolide azithromycin is a critically important clinical antimicrobial,1 increasingly used as an alternative when typical first-line antimicrobials (e.g. quinolones) are no longer effective in the treatment of severe cases of bacterial gastrointestinal infections.2–5 Considering that azithromycin is one of the few available options for treatment of MDR bacteria and that the majority of the azithromycin resistance genes are acquired, the spread of azithromycin resistance could seriously...